Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Mice Expressing a "Hyper-Sensitive" Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor Diabetic.

Marcus DJ, Zee ML, Davis BJ, Haskins CP, Andrews MJ, Amin R, Henderson-Redmond AN, Mackie K, Czyzyk TA, Morgan DJ.

PLoS One. 2016 Aug 8;11(8):e0160462. doi: 10.1371/journal.pone.0160462.

2.

Subsarcolemmal mitochondria isolated with the proteolytic enzyme nagarse exhibit greater protein specific activities and functional coupling.

Kras KA, Willis WT, Barker N, Czyzyk T, Langlais PR, Katsanos CS.

Biochem Biophys Rep. 2016 Jul 1;6:101-107.

PMID:
27092336
3.

Long-term consequences of perinatal fatty acid amino hydrolase inhibition.

Wu CS, Morgan D, Jew CP, Haskins C, Andrews MJ, Leishman E, Spencer CM, Czyzyk T, Bradshaw H, Mackie K, Lu HC.

Br J Pharmacol. 2014 Mar;171(6):1420-34. doi: 10.1111/bph.12500.

4.

Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice.

Morgan DJ, Davis BJ, Kearn CS, Marcus D, Cook AJ, Wager-Miller J, Straiker A, Myoga MH, Karduck J, Leishman E, Sim-Selley LJ, Czyzyk TA, Bradshaw HB, Selley DE, Mackie K.

J Neurosci. 2014 Apr 9;34(15):5152-63. doi: 10.1523/JNEUROSCI.3445-12.2014.

5.

Targeted disruption of G0/G1 switch gene 2 enhances adipose lipolysis, alters hepatic energy balance, and alleviates high-fat diet-induced liver steatosis.

Zhang X, Xie X, Heckmann BL, Saarinen AM, Czyzyk TA, Liu J.

Diabetes. 2014 Mar;63(3):934-46. doi: 10.2337/db13-1422.

6.

Genetic ablation of myelin protein zero-like 3 in mice increases energy expenditure, improves glycemic control, and reduces hepatic lipid synthesis.

Czyzyk TA, Andrews JL, Coskun T, Wade MR, Hawkins ED, Lockwood JF, Varga G, Sahr AE, Chen Y, Brozinick JT, Kikly K, Statnick MA.

Am J Physiol Endocrinol Metab. 2013 Jul 15;305(2):E282-92. doi: 10.1152/ajpendo.00228.2013.

7.

Deficiency of the RIIβ subunit of PKA affects locomotor activity and energy homeostasis in distinct neuronal populations.

Zheng R, Yang L, Sikorski MA, Enns LC, Czyzyk TA, Ladiges WC, McKnight GS.

Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):E1631-40. doi: 10.1073/pnas.1219542110.

8.

Mice lacking δ-opioid receptors resist the development of diet-induced obesity.

Czyzyk TA, Romero-Picó A, Pintar J, McKinzie JH, Tschöp MH, Statnick MA, Nogueiras R.

FASEB J. 2012 Aug;26(8):3483-92. doi: 10.1096/fj.12-208041.

9.

CNS opioid signaling separates cannabinoid receptor 1-mediated effects on body weight and mood-related behavior in mice.

Lockie SH, Czyzyk TA, Chaudhary N, Perez-Tilve D, Woods SC, Oldfield BJ, Statnick MA, Tschöp MH.

Endocrinology. 2011 Oct;152(10):3661-7. doi: 10.1210/en.2011-1220.

PMID:
21810947
10.

The propeptide precursor proSAAS is involved in fetal neuropeptide processing and body weight regulation.

Morgan DJ, Wei S, Gomes I, Czyzyk T, Mzhavia N, Pan H, Devi LA, Fricker LD, Pintar JE.

J Neurochem. 2010 Jun;113(5):1275-84. doi: 10.1111/j.1471-4159.2010.06706.x.

11.

A model of binge-like eating behavior in mice that does not require food deprivation or stress.

Czyzyk TA, Sahr AE, Statnick MA.

Obesity (Silver Spring). 2010 Sep;18(9):1710-7. doi: 10.1038/oby.2010.46.

12.

kappa-Opioid receptors control the metabolic response to a high-energy diet in mice.

Czyzyk TA, Nogueiras R, Lockwood JF, McKinzie JH, Coskun T, Pintar JE, Hammond C, Tschöp MH, Statnick MA.

FASEB J. 2010 Apr;24(4):1151-9. doi: 10.1096/fj.09-143610.

13.

Interactions of peptide amidation and copper: novel biomarkers and mechanisms of neural dysfunction.

Bousquet-Moore D, Prohaska JR, Nillni EA, Czyzyk T, Wetsel WC, Mains RE, Eipper BA.

Neurobiol Dis. 2010 Jan;37(1):130-40. doi: 10.1016/j.nbd.2009.09.016.

14.

GOAT links dietary lipids with the endocrine control of energy balance.

Kirchner H, Gutierrez JA, Solenberg PJ, Pfluger PT, Czyzyk TA, Willency JA, Schürmann A, Joost HG, Jandacek RJ, Hale JE, Heiman ML, Tschöp MH.

Nat Med. 2009 Jul;15(7):741-5. doi: 10.1038/nm.1997. Erratum in: Nat Med. 2009 Sep;15(9):1093.

15.

Reversal of physiological deficits caused by diminished levels of peptidylglycine alpha-amidating monooxygenase by dietary copper.

Bousquet-Moore D, Ma XM, Nillni EA, Czyzyk TA, Pintar JE, Eipper BA, Mains RE.

Endocrinology. 2009 Apr;150(4):1739-47. doi: 10.1210/en.2008-1202.

16.

Disruption of the RIIbeta subunit of PKA reverses the obesity syndrome of Agouti lethal yellow mice.

Czyzyk TA, Sikorski MA, Yang L, McKnight GS.

Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):276-81. doi: 10.1073/pnas.0710607105.

17.

Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice.

Ansonoff MA, Zhang J, Czyzyk T, Rothman RB, Stewart J, Xu H, Zjwiony J, Siebert DJ, Yang F, Roth BL, Pintar JE.

J Pharmacol Exp Ther. 2006 Aug;318(2):641-8.

18.

Deletion of peptide amidation enzymatic activity leads to edema and embryonic lethality in the mouse.

Czyzyk TA, Ning Y, Hsu MS, Peng B, Mains RE, Eipper BA, Pintar JE.

Dev Biol. 2005 Nov 15;287(2):301-13.

19.

Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine.

Chefer VI, Czyzyk T, Bolan EA, Moron J, Pintar JE, Shippenberg TS.

J Neurosci. 2005 May 18;25(20):5029-37.

20.

Autoradiography in opioid triple knockout mice reveals opioid and opioid receptor like binding of naloxone benzoylhydrazone.

Cox V, Clarke S, Czyzyk T, Ansonoff M, Nitsche J, Hsu MS, Borsodi A, Tömböly C, Tóth G, Hill R, Pintar J, Kitchen I.

Neuropharmacology. 2005 Feb;48(2):228-35.

PMID:
15695161
Items per page

Supplemental Content

Loading ...
Support Center